Call for Applications: Strengthening African Malaria Research Institutions, 10/05

This call is also posted on http://www.amanet-trust.org
Deadline for applications: Friday, September 30, 2005

Background and justification

The Current failure of efforts to contain malaria calls for research in other potential intervention tools. Currently there are many malaria vaccine candidate molecules at various stages in the development pipeline. Those that eventually reach clinical testing stages will require to be tested in malaria endemic African populations before licensure and deployment. Unfortunately, very few African-led institutions have the capacity and technical ability to undertake malaria vaccine trials. In recognition of these problems, the African Malaria Network Trust (AMANET) seeks to contribute to the speedy development of effective malaria vaccines by preparing African owned and led malaria research institutions for vaccine testing as well as identification and sponsorship of promising vaccine candidates. Over the next five years AMANET intends to support several centres to be able to conduct vaccine trials from phase-1 (safety) to phase-3 multi-centre trials across various eco-epidemiological malaria settings. It is a matter of policy that AMANET will ONLY fund African owned and led research institutions in this regard.

This is a second call intended to assist an African malaria research institution to develop capacity for conducting malaria vaccine trials at phases 1-3. This grant which may last 1-3
years should allow a research institution which is strategically placed, but is incapacitated by infrastructural weaknesses, inadequate skilled personnel or lack of equipment to undergo capacity development so as to upgrade it, while at the same time undertake wholesome characterisation of its intended field site.

Interested institutions should submit a detailed two to three page letter of intent. The letter should outline a plan to meet the expected objectives. It is critically important to show how limiting weaknesses will be overcome through this grant i.e. human resources, poor infrastructure, functioning of ethical review bodies and care for research participants. Applying institutions must clearly demonstrate national commitment to their development, preferably within the framework of the ministries of health in their country.

Only applications submitted by institutional heads/leaders will be considered.

How to apply

Completed applications with the above requirements must be sent by e-mail mailto:(info@amanet-trust.org) and received at the AMANET secretariat by Friday 30th September 2005.

All applications must be directed to:

The Managing Trustee
African Malaria Network Trust (AMANET)
Tanzania Commission for Science and Technology Building
Ali Hassan Mwinyi Road
P.O Box 33207
Dar es Salaam, Tanzania
Tel: +255-22-2700-018

Fax: +255-22-2700-380
mailto:info@amanet-trust.org
http://www.amanet-trust.org

Short listed applicants will be requested to submit their detailed proposals during October 2005.

Dr Charles L. Wanga
Communications Officer
African Malaria Network Trust [AMANET]
Room D30, 3rd Floor
Tanzania Commission for Science and Technology Building
Ali Hassan Mwinyi Road
P.O. BOX 33207
Dar es Salaam, Tanzania
Cell:+255-74-8337-232
Tel: +255-22-2700-018

Fax: +255-22-2700-380
mailto:clwanga@amanet-trust.org

Page Editor: Ali B. Ali-Dinar, Ph.D.